DJIA 17,031.14 43.63 0.26%
NASDAQ 4,518.90 -48.70 -1.07%
S&P 500 1,984.13 -1.41 -0.07%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

92.13 -0.86 (-0.92%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRTX $92.13 -0.92%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $92.81
Previous Close $92.99
Daily Range $91.27 - $92.81
52-Week Range $58.06 - $99.74
Market Cap $21.9B
P/E Ratio -46.73
Dividend (Yield) $0.00 (0.0%)
Volume 1,150,814
Average Daily Volume 1,207,111
Current FY EPS -$2.81





Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website:

News & Commentary Rss Feed

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Nasdaq 100 Movers: VRTX, YHOO

Uncertainty Prevails For Vertex

3 Stocks Underperforming Today In The Health Care Sector

Benzinga's Top Upgrades

Goldman Sachs Upgrades Vertex Pharmaceuticals To Buy

Commit To Buy Vertex Pharmaceuticals At $60, Earn 6.7% Using Options

S&P 500 Movers: KORS, VRTX

Vertex Pharmaceuticals (VRTX) Is Today's Strong On High Volume Stock

Analysts' Actions: Ciena, Finisar, Vertex and More

See More VRTX News...

VRTX's Top Competitors

VRTX $92.13 (-0.92%)
Current stock: VRTX
AMGN $137.97 (0.06%)
Current stock: AMGN
GILD $100.99 (-2.58%)
Current stock: GILD
BIIB $320.12 (-1.01%)
Current stock: BIIB